Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease

Lupus

Volumn 21, Issue 2, 2012, Pages 175-183

  Perdan Pirkmajer, K ^a   Thallinger, G G ^b   Snoj, N ^a   Cucnik S ^a   Zigon P ^a   Kveder, T ^a   Logar, D ^a   Praprotnik, S ^a   Tomsic M ^a   Sodin Semrl, S ^a   Ambrozic A ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

autoantibodies; autoimmunity; H1N1 influenza; patients; seasonal influenza; vaccination

Indexed keywords

INFLUENZA VACCINE;

ADULT; ANTIBODY PRODUCTION; ANTIBODY SCREENING; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION PREVENTION; INFLAMMATORY DISEASE; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATIC DISEASE; SEASONAL INFLUENZA; SIDE EFFECT;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RHEUMATIC DISEASES; VACCINATION;

EID: 84855779051     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311429817     Document Type: Article

References (36)

1. Falagas ME, Manta KG, Betsi GI, Pappas G. Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol. 2007 ; 26: 663-670 (Pubitemid 46554069)
2. Hak E, Nordin J, Wei F, et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis. 2002 ; 35: 370-377 (Pubitemid 34852565)
3. Löbermann M, Boršo D, Hilgendorf I, Fritzsche C, Zettl UK, Reisinger EC. Immunization in the adult immunocompromised host. Autoimmun Rev. 2011 ;:
4. van Assen S, Agmon-Levin N, Elkayam O, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2011 ; 70: 414-422
5. van Assen S, Elkayam O, Agmon-Levin N, et al. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev. 2011 ; 10: 341-352
6. Saad CG, Borba EF, Aikawa NE, et al. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases. Ann Rheum Dis. 2011 ; 70: 1068-1073
7. Blank M, Krause I, Fridkine M, Keller N, Shoenfeld Y. Molecular mimicry: lessons from an experimental model of antiphospholipid syndrome in naive mice. Isr Med Assoc J. 2000 ; 2 (Suppl). S20 - S21
8. Pierangeli SS, Blank M, Liu X, et al. A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo. J Autoimmun. 2004 ; 22: 217-225 (Pubitemid 38372192)
9. Shoenfeld Y, Blank M, Krause I. The relationship of antiphospholipid antibodies to infections-do they bind to infecting agents or may they even be induced by them?. Clin Exp Rheumatol. 2000 ; 18: 431-432 (Pubitemid 30616936)
10. Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol. 2009 ; 5: 648-652
11. Toplak N, Avcin T. Influenza and autoimmunity. Ann N Y Acad Sci. 2009 ; 1173: 619-626
12. Haber P, DeStefano F, Angulo FJ, et al. Guillain-Barré syndrome following influenza vaccination. JAMA. 2004 ; 292: 2478-2481 (Pubitemid 39552672)
13. Iyngkaran P, Limaye V, Hill C, Henderson D, Pile KD, Rischmueller M. Rheumatoid vasculitis following influenza vaccination. Rheumatology (Oxford). 2003 ; 42: 907-909 (Pubitemid 37220947)
14. Uji M, Matsushita H, Iwata S. Microscopic polyangiitis after influenza vaccination. Intern Med. 2005 ; 44: 892-896 (Pubitemid 41263842)
15. Hermann R, Pfeil A, Busch M, et al. Very severe thrombotic thrombocytopenic purpura (TTP) after H1N1 vaccination [Article in German]. Med Klin (Munich). 2010 ; 105: 663-668
16. Toplak N, Kveder T, Trampus-Bakija A, Subelj V, Cucnik S, Avcin T. Autoimmune response following annual influenza vaccination in 92 apparently healthy adults. Autoimmun Rev. 2008 ; 8: 134-138
17. Kapetanovic MC, Saxne T, Nilsson JA, Geborek P. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford). 2007 ; 46: 608-611 (Pubitemid 46523304)
18. Gelinck LB, van der Bijl AE, Beyer WE, et al. The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis. 2008 ; 67: 713-716 (Pubitemid 351571939)
19. Kaine JL, Kivitz AJ, Birbara C, Luo AY. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol. 2007 ; 34: 272-379
20. Setti M, Fenoglio D, Ansaldi F, et al. Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients. Vaccine. 2009 ; 27: 3367-3372
21. Elkayam O, Amir S, Mendelson E, et al. Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases. Arthritis Care Res (Hoboken). 2011 ; 63: 1062-1067
22. Tarján P, Sipka S, Lakos G, Kiss E, Ujj G, Szegedi G. Influenza vaccination and the production of anti-phospholipid antibodies in patients with systemic lupus erythematosus. Scand J Rheumatol. 2006 ; 35: 241-243 (Pubitemid 43890747)
23. Abu-Shakra M, Press J, Buskila D, Sukenik S. Influenza vaccination of patients with systemic lupus erythematosus: safety and immunogenecity issues. Autoimmun Rev. 2007 ; 6: 543-546 (Pubitemid 47374614)
24. Lu CC, Wang YC, Lai JH, Lee TS, Lin HT, Chang DM. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity. Vaccine. 2011 ; 29: 444-450
25. Bunn C, Kveder T Manual of biological markers of disease. van Venrooij WJ Maini RN, ed. Dordrecht/Boston/London: Kluwer Academic Publishers ; 1993: 1-12.
26. Ambrozic A, Avicin T, Ichikawa K, et al. Anti-beta(2)-glycoprotein I antibodies in children with atopic dermatitis. Int Immunol. 2002 ; 14: 823-830 (Pubitemid 34814643)
27. Cucnik S, Ambrozic A, Bozic B, Skitek M, Kveder T. Anti-beta2- glycoprotein I ELISA: methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards. Clin Chem Lab Med. 2000 ; 38: 777-783
28. Avcin T, Ambrozic A, Bozic B, Accetto M, Kveder T, Rozman B. Estimation of anticardiolipin antibodies, anti-beta2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis. Clin Exp Rheumatol. 2002 ; 20: 101-108 (Pubitemid 34213744)
29. Stegnar M, Bozic B, Peternel P, Kveder T, Vene N, Rozman B. Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis. Thromb Res. 1991 ; 63: 433-443
30. Abu-Shakra M, Press J, Sukenik S, Buskila D. Influenza virus vaccination of patients with SLE: effects on generation of autoantibodies. Clin Rheumatol. 2002 ; 21: 369-372
31. Petri M. Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort. Lupus. 2010 ; 19: 419-423
32. Reeves WH, Lee PY, Weinstein JS, Satoh M, Lu L. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol. 2009 ; 30: 455-464
33. Holmdahl R, Lorentzen JC, Lu S, et al., Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol Rev 2001;184:184-202. (Pubitemid 34123775)
34. Pellegrini M, Nicolay U, Lindert K, Groth N, Della Cioppa G. MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. Vaccine. 2009 ; 27: 6959-6965
35. Rose NR. Autoimmunity, infection and adjuvants. Lupus. 2010 ; 19: 354-358
36. Shoenfeld Y, Agmon-Levin N. 'ASIA'-autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011 ; 36: 4-8